Amy Belt Raimundo Joins NuVasive Board

NuVasive Inc., the leader in spine technology innovation, has appointed Amy Belt Raimundo to its Board of Directors. 
 
Raimundo has more than 20 years of experience in healthcare, with extensive knowledge in medical technology, healthcare strategy, and digital health. Currently, she is the co-founder and managing partner for Convey Capital, a venture capital fund focused on making investments in healthcare technology.  
 
“Amy is a fantastic addition to our Board of Directors with her deep knowledge of the healthcare landscape and bringing disruptive technologies to market,” said J. Christopher Barry, CEO of NuVasive. “As we make progress against our long-term strategy with multiple vectors of growth, Amy’s experience investing into and commercializing novel technology will further our ability to change the lives of patients around the globe.”
 
Prior to Convey Capital, Raimundo was the managing director for Kaiser Permanente Ventures, a national leader in strategic venture investing in healthcare. Before Kaiser Permanente Ventures, she was the chief business officer at Evidation Health, a leader in digital health and disease data management. Prior to Evidation Health, Raimundo served as vice president for Covidien Ventures, a venture capital group focused on investing in companies developing innovative medical devices and diagnostic technologies. She also was a vice president at Advanced Technology Ventures, where she helped transform emerging growth healthcare companies into market leaders. Earlier in her career, Raimundo held operating roles at Guidant Corporation and served as a management consultant for APM/CSC Healthcare, where she optimized clinical workflow and guidelines for major hospital systems.
 
“I have spent my entire career helping transform the future of healthcare through bringing innovative solutions to market,” said Raimundo. “As the leader of spine innovation and with its robust technology pipeline, NuVasive is well-positioned to help change the future of spine surgery. I look forward to supporting the company as it advances the standard of patient care.”
 
Raimundo is a Kauffman Fellow, as well as co-founder of MedtechWomen, a nonprofit organization dedicated to highlighting women leaders in the medical technology industry. Raimundo earned a bachelor of arts degree in economics from Yale University and an M.B.A. from the University of California, Berkeley.  
 
NuVasive Inc.’s less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. Its procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients.